Jennison Associates’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,412,577
| Closed | -$7.34M | – | 860 |
|
|
2016
Q4 | $7.34M | Buy |
1,412,577
+2,909
| +0.2% | +$13.7K | 0.01% | 496 |
|
|
2016
Q3 | $6.58M | Sell |
1,409,668
-3,866
| -0.3% | -$18K | 0.01% | 497 |
|
|
2016
Q2 | $5.57M | Sell |
1,413,534
-953
| -0.1% | -$3.56K | 0.01% | 496 |
|
|
2016
Q1 | $4.38M | Buy |
1,414,487
+6,981
| +0.5% | +$23.4K | ﹤0.01% | 495 |
|
|
2015
Q4 | $6.43M | Buy |
1,407,506
+261,818
| +23% | +$1.24M | 0.01% | 505 |
|
|
2015
Q3 | $5.4M | Buy |
1,145,688
+5,242
| +0.5% | +$33.8K | 0.01% | 540 |
|
|
2015
Q2 | $8.17M | Buy |
1,140,446
+3,518
| +0.3% | +$26.5K | 0.01% | 524 |
|
|
2015
Q1 | $9.63M | Buy |
1,136,928
+262
| +0% | +$2.23K | 0.01% | 497 |
|
|
2014
Q4 | $10.6M | Sell |
1,136,666
-12,648
| -1% | -$110K | 0.01% | 483 |
|
|
2014
Q3 | $9.57M | Buy |
1,149,314
+1,374
| +0.1% | +$12.7K | 0.01% | 485 |
|
|
2014
Q2 | $13.3M | Sell |
1,147,940
-123,981
| -10% | -$1.27M | 0.01% | 463 |
|
|
2014
Q1 | $16.1M | Buy |
1,271,921
+3,449
| +0.3% | +$44.6K | 0.02% | 459 |
|
|
2013
Q4 | $13.7M | Buy |
1,268,472
+4,010
| +0.3% | +$46.6K | 0.01% | 469 |
|
|
2013
Q3 | $15.7M | Sell |
1,264,462
-3,585
| -0.3% | -$49.6K | 0.02% | 454 |
|
|
2013
Q2 | $16.9M | Buy |
+1,268,047
| New | +$16.3M | 0.02% | 445 |
|
Other funds holding DSCI
Jennison Associates's DSCI Position: Q1 2017 in Review
Jennison Associates sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 1,412,577 shares — an estimated $7.34M sold.
Jennison Associates first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $16.9M in Q2 2013. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Jennison Associates reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- Jennison Associates sold 1,412,577 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $7.34M.
- Jennison Associates first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
- Jennison Associates's Derma Sciences, Inc. Common Stock (DE) position peaked at $16.9M in Q2 2013.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.